AIM ImmunoTech Inc (AIM)

0.1876 0.00 (0.00%) USD  |  NYAM  |  Dec 23, 16:00
0.20 +0.01 (+6.61%) Pre-Market: 09:10
More

AIM ImmunoTech Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Perspective Therapeutics Inc --
Protalix BioTherapeutics Inc Upgrade
Electromed Inc Upgrade
Xtant Medical Holdings Inc Upgrade
Armata Pharmaceuticals Inc --